RAPT Therapeutics (RAPT) Net Income (2020 - 2023)
Historic Net Income for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to -$33.2 million.
- Therapeutics' Net Income fell 3596.25% to -$33.2 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$33.2 million, marking a year-over-year increase of 7191.57%. This contributed to the annual value of -$127.1 million for FY2023, which is 4809.95% down from last year.
- Latest data reveals that Therapeutics reported Net Income of -$33.2 million as of Q4 2023, which was down 3596.25% from -$33.9 million recorded in Q3 2023.
- In the past 5 years, Therapeutics' Net Income registered a high of -$12.4 million during Q2 2020, and its lowest value of -$33.9 million during Q3 2023.
- In the last 4 years, Therapeutics' Net Income had a median value of -$18.8 million in 2021 and averaged -$20.9 million.
- As far as peak fluctuations go, Therapeutics' Net Income plummeted by 1622.97% in 2022, and later tumbled by 5646.74% in 2023.
- Therapeutics' Net Income (Quarter) stood at -$12.7 million in 2020, then plummeted by 40.79% to -$17.9 million in 2021, then tumbled by 36.27% to -$24.4 million in 2022, then crashed by 35.96% to -$33.2 million in 2023.
- Its last three reported values are -$33.2 million in Q4 2023, -$33.9 million for Q3 2023, and -$28.4 million during Q2 2023.